These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 1287616

  • 41. A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice.
    Tilyard MW, Dovey SM.
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):97S-101S. PubMed ID: 1617932
    [Abstract] [Full Text] [Related]

  • 42. [A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
    Oshima S, Yokoyama Y, Kikuiri T, Murakami T, Nishihara H, Shimizu T, Abe M, Kurihara Y, Itoh C, Takeuchi K.
    Jpn J Antibiot; 1986 Oct; 39(10):2726-53. PubMed ID: 3543432
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis.
    Wettengel R, Vetter N, Waardenburg FA.
    J Antimicrob Chemother; 1993 Jun; 31(6):963-72. PubMed ID: 8360133
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Cefaclor and amoxycillin in the treatment of infective exacerbations of chronic bronchitis.
    Law MR, Holt HA, Reeves DS, Hodson ME.
    J Antimicrob Chemother; 1983 Jan; 11(1):83-8. PubMed ID: 6337988
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Cefaclor treatment of upper and lower respiratory tract infections caused by Moraxella catarrhalis.
    Oberlin JA, Hyslop DL.
    Pediatr Infect Dis J; 1990 Jan; 9(1):41-4. PubMed ID: 2105479
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
    McCarty J, Ruoff GE, Jacobson KD.
    Am J Med; 1992 Jun 22; 92(6A):80S-85S. PubMed ID: 1621751
    [Abstract] [Full Text] [Related]

  • 53. Cefaclor into the millennium.
    Brumfitt W, Hamilton-Miller JM.
    J Chemother; 1999 Jun 22; 11(3):163-78. PubMed ID: 10435677
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Comparative clinical efficacy of cefetamet pivoxil in lower respiratory tract infection.
    Grassi GG.
    Drugs; 1994 Jun 22; 47 Suppl 3():35-42. PubMed ID: 7518765
    [Abstract] [Full Text] [Related]

  • 56. Cefaclor in the treatment of chronic bronchitis.
    J Antimicrob Chemother; 1991 Jul 22; 28(1):141-4. PubMed ID: 1769933
    [No Abstract] [Full Text] [Related]

  • 57. [A clinical study on S6472, sustained release preparation of cefaclor, dermatological area].
    Kawanami T, Shibata A, Hanawa S, Morishima T.
    Jpn J Antibiot; 1990 Sep 22; 43(9):1621-8. PubMed ID: 2262967
    [Abstract] [Full Text] [Related]

  • 58. Antibiotics for exacerbations of chronic bronchitis?
    Lancet; 1987 Jul 04; 2(8549):23-4. PubMed ID: 2885508
    [No Abstract] [Full Text] [Related]

  • 59. Cefaclor in the treatment of chronic bronchitis.
    Maesen FP, Geraedts WH, Davies BI.
    J Antimicrob Chemother; 1990 Sep 04; 26(3):456-8. PubMed ID: 2228836
    [No Abstract] [Full Text] [Related]

  • 60. Antibiotics for exacerbations of chronic bronchitis.
    Manresa F, Blavia R, Martin R, Liñares J, Rodriguez B, Verdaguer R.
    Lancet; 1987 Aug 15; 2(8555):394-5. PubMed ID: 2886848
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.